Explore our brands

Our brands bring together the industry's most influential leaders and scientific experts, inspiring thought-provoking and insightful content that offers a unique perspective on R&D trends and challenges.
Contact

Resources

For the latest in precision medicine, sign up for our monthly newsletter to be among the first to receive
exclusive insights, in-depth market analyses, and expert articles directly to your inbox

A New Golden Age for Target Identification: Accessing the Novel Druggable Space with Discovery Proteomics

On-demand webinar presented by Mo Jain, MD, PhD, Founder and CEO, Sapient and Jonathan Usuka, PhD, MBA Chief Business Officer, Sapient
Watch Now

Accelerate Protein Screening by Sequencing Protein Barcodes on Platinum®

On-demand webinar presented by Joel McDade, PhD, Sr. Commercial Business Development Manager, Quantum-Si and Bonnie Lun, PhD, Field Application Scientist
Watch Now

Challenges and Strategies for the Application of Omics and Spatial Technologies

A concise report featuring insights from the prominent thought leaders of Omics 2023 and Spatial 2024
Read Now

Top R&D Stories of 2023

Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.
Read Now
Biomarker Discovery & Development

Optimer - Accelerating Your Journey to the Clinic

Read More
Biomarker Discovery & Development

Optimer - Drug Conjugates

Read More
Biomarker Discovery & Development

Optimer - Enabled Small Molecule Detection and Analysis

Read More
Biomarker Discovery & Development

Optimer Diagnostic Reagent COVID-19 Datapack

Read More
Spatial Analysis

Regulation & Policy: Interview with Arvind Rao, Associate Professor of Biostatistics at the University of Michigan

Arvind Rao, Associate Professor of Biostatistics at the University of Michigan, discusses the regulatory challenges and opportunities of biomedical informatics.
Read More
Biomarker Discovery & Development

Supelco - BIOshell Peptide Mapping Trastuzumab UHPLC-MS

Read More
Biomarker Discovery & Development

Supelco - Supel Carbon N-Glycan Human IgG

Read More
Biomarker Discovery & Development

The Optimer Discovery Platform

Read More
Biomarker Discovery & Development

Whole Exome Sequencing (WES) Data Generation Service

Read More
Genome Editing

Regulation & Policy: Interview with John Parrington, Associate Professor of Cellular and Molecular Pharmacology, University of Oxford

John Parrington, Associate Professor of Cellular and Molecular Pharmacology & Fellow of Worcester College, University of Oxford, discusses the regulatory challenges and opportunities of genome editing.
Read More
Single Cell Analysis

Navigating Post-Translational Modifications in Single-Cell Analysis

What are the current opportunities and challenges facing single-cell analysis today? We ask key opinion leaders from Janssen Pharmaceuticals, SciLifeLab, and the Karolinska Institutet.
Read More
Clinical Development

Surrogate Biomarkers in NASH and Liver Cirrhosis: Qualifying for Clinical Trial Validation and Legislative Success

Highly involved treatment scenarios and prognostics are required to properly assess best-practice approaches for investigating issues posed by NASH and liver cirrhosis. Surrogate biomarkers present a less invasive approach to assessing these outcomes.
Read More

Subscribe to Our Newsletter

Sign up for our monthly newsletter to
keep up with all things discovery